Karijolich et al., 2014 - Google Patents
Kaposi's sarcoma-associated herpesvirus ORF45 mediates transcriptional activation of the HIV-1 long terminal repeat via RSK2Karijolich et al., 2014
View PDF- Document ID
- 5641261076298607577
- Author
- Karijolich J
- Zhao Y
- Peterson B
- Zhou Q
- Glaunsinger B
- Publication year
- Publication venue
- Journal of Virology
External Links
Snippet
Robust activation of human immunodeficiency virus type 1 (HIV-1) gene expression occurs upon superinfection with Kaposi's sarcoma-associated herpesvirus (KSHV), a common AIDS- associated pathogen. Though the mechanisms underlying this phenotype remain unknown …
- 101710031382 HI_1518 0 title abstract description 139
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Karijolich et al. | Kaposi's sarcoma-associated herpesvirus ORF45 mediates transcriptional activation of the HIV-1 long terminal repeat via RSK2 | |
| Glass et al. | Components of promyelocytic leukemia nuclear bodies (ND10) act cooperatively to repress herpesvirus infection | |
| Krishna et al. | Human cytomegalovirus G protein-coupled receptor US28 promotes latency by attenuating c-fos | |
| King et al. | Inhibition of human adenovirus replication by the importin α/β1 nuclear import inhibitor ivermectin | |
| Kim et al. | SAMHD1 restricts herpes simplex virus 1 in macrophages by limiting DNA replication | |
| Tavalai et al. | Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection | |
| Frampton Jr et al. | Equine herpesvirus 1 enters cells by two different pathways, and infection requires the activation of the cellular kinase ROCK1 | |
| Hau et al. | Role of ATM in the formation of the replication compartment during lytic replication of Epstein-Barr virus in nasopharyngeal epithelial cells | |
| Kuang et al. | Activation of p90 ribosomal S6 kinase by ORF45 of Kaposi's sarcoma-associated herpesvirus and its role in viral lytic replication | |
| Habiger et al. | Interferon kappa inhibits human papillomavirus 31 transcription by inducing Sp100 proteins | |
| Zou et al. | Guanylate-binding protein 1 inhibits nuclear delivery of Kaposi's sarcoma-associated herpesvirus virions by disrupting formation of actin filament | |
| Fortunato et al. | Infection of cells with human cytomegalovirus during S phase results in a blockade to immediate-early gene expression that can be overcome by inhibition of the proteasome | |
| Paladino et al. | Identification of herpesvirus proteins that contribute to G1/S arrest | |
| Wang et al. | Ku70 senses HTLV-1 DNA and modulates HTLV-1 replication | |
| Mercorelli et al. | Drug repurposing approach identifies inhibitors of the prototypic viral transcription factor IE2 that block human cytomegalovirus replication | |
| Sun et al. | Kaposi's sarcoma-associated herpesvirus-encoded LANA can induce chromosomal instability through targeted degradation of the mitotic checkpoint kinase Bub1 | |
| Yan et al. | Inhibition of Kaposi's sarcoma-associated herpesvirus lytic replication by HIV-1 Nef and cellular microRNA hsa-miR-1258 | |
| Lu et al. | The single RBP-Jκ site within the LANA promoter is crucial for establishing Kaposi's sarcoma-associated herpesvirus latency during primary infection | |
| Persson et al. | Wide-scale use of Notch signaling factor CSL/RBP-Jκ in RTA-mediated activation of Kaposi's sarcoma-associated herpesvirus lytic genes | |
| Shen et al. | Ribosome protein L4 is essential for Epstein–Barr virus nuclear antigen 1 function | |
| Tarnita et al. | Contribution of DNA replication to the FAM111A-mediated simian virus 40 host range phenotype | |
| Cheng et al. | Screening of the human kinome identifies MSK1/2-CREB1 as an essential pathway mediating Kaposi's sarcoma-associated herpesvirus lytic replication during primary infection | |
| Sun et al. | Cellular requirements for sensing and elimination of incoming HSV-1 DNA and capsids | |
| van Domselaar et al. | HIV-1 subtype C with PYxE insertion has enhanced binding of Gag-p6 to host cell protein ALIX and increased replication fitness | |
| Chang et al. | Identification and characterization of two novel spliced genes located in the orf47-orf46-orf45 gene locus of Kaposi's sarcoma-associated herpesvirus |